- Report
- October 2025
- 195 Pages
Global
From €3145EUR$3,545USD£2,745GBP
€3495EUR$3,939USD£3,050GBP
- Report
- October 2025
- 194 Pages
Global
From €5190EUR$5,850USD£4,530GBP
- Report
- May 2025
- 149 Pages
Global
From €2262EUR$2,549USD£1,974GBP
€2661EUR$2,999USD£2,322GBP
- Report
- February 2025
- 200 Pages
Global
From €3983EUR$4,490USD£3,477GBP
- Report
- October 2025
- 179 Pages
Global
From €5190EUR$5,850USD£4,530GBP
- Report
- February 2025
- 200 Pages
Global
From €3983EUR$4,490USD£3,477GBP
- Report
- May 2024
- 182 Pages
Global
From €3992EUR$4,500USD£3,485GBP
- Newsletter
- October 2025
- 5 Pages
Global
From €116EUR$131USD£101GBP
- Company Profile
- October 2024
- 35 Pages
From €665EUR$750USD£581GBP
- Report
- November 2023
- 162 Pages
Global
From €2218EUR$2,500USD£1,936GBP
- Report
- August 2023
- 149 Pages
Asia Pacific
From €1331EUR$1,500USD£1,162GBP
- Report
- August 2023
- 147 Pages
Europe
From €1331EUR$1,500USD£1,162GBP
- Report
- August 2023
- 148 Pages
Africa, Middle East
From €1331EUR$1,500USD£1,162GBP
- Report
- August 2023
- 140 Pages
North America
From €1331EUR$1,500USD£1,162GBP
- Report
- August 2023
- 284 Pages
Global
From €3194EUR$3,600USD£2,788GBP
- Report
- August 2023
- 117 Pages
Global
From €5279EUR$5,950USD£4,608GBP
- Report
- June 2023
- 140 Pages
Global
From €4391EUR$4,949USD£3,833GBP
- Report
- April 2023
- 110 Pages
Global
From €4214EUR$4,750USD£3,678GBP
- Report
- January 2022
- 120 Pages
Global
From €4214EUR$4,750USD£3,678GBP
-
Journal - October 2025
- 58 Pages
Global
From €377EUR$425USD£329GBP

The Neurosciences market is a sector of the healthcare industry that focuses on the study of the nervous system and its diseases. It includes research, diagnosis, and treatment of neurological disorders such as Alzheimer's, Parkinson's, and Multiple Sclerosis. Neurosciences also covers the development of medical devices and treatments for neurological conditions. Companies in this market include AbbVie, Biogen, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, and Sanofi. These companies are involved in the development of drugs, medical devices, and treatments for neurological conditions. Additionally, they are involved in research and development of new treatments and therapies for neurological diseases. Show Less Read more